Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $1.552B (100.0% shares, 0.0% debt)

Holdings (27)

VTI VANGUARD INDEX FDS 22.0%

Value $341M Shares 1,038,550 Est. Cost $267.51 Unrealized —

BN BROOKFIELD CORP 10.3%

Value $160M Shares 2,330,830 Est. Cost $22.16 Unrealized +99.4%

ASML ASML HOLDING N V 9.1%

Value $141M Shares 145,836 Est. Cost $662.32 Unrealized —

MIRM MIRUM PHARMACEUTICALS INC 6.0%

Value $92.67M Shares 1,264,028 Est. Cost $12.27 Unrealized +418.3%

EWTX EDGEWISE THERAPEUTICS INC 5.6%

Value $86.78M Shares 5,350,000 Est. Cost $18.02 Unrealized -21.3%

CRM SALESFORCE INC 5.0%

Value $78.25M Shares 330,187 Est. Cost $205.72 Unrealized +22.2%

— MERUS N V 4.6%

Value $70.61M Shares 750,000 Est. Cost $56.95 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 4.4%

Value $67.68M Shares 1,625,000 Est. Cost $25.38 Unrealized +26.0%

VRDN VIRIDIAN THERAPEUTICS INC 3.3%

Value $51.36M Shares 2,380,000 Est. Cost $16.63 Unrealized +8.5%

BABA ALIBABA GROUP HLDG LTD 3.0%

Value $45.99M Shares 257,327 Est. Cost $165.09 Unrealized —

ZBIO ZENAS BIOPHARMA INC 2.9%

Value $44.4M Shares 2,000,000 Est. Cost $14.60 Unrealized +11.5%

PHVS PHARVARIS N V 2.8%

Value $43.66M Shares 1,750,000 Est. Cost $15.36 Unrealized +44.4%

RXRX RECURSION PHARMACEUTICALS IN 2.5%

Value $38.7M Shares 7,929,835 Est. Cost $6.72 Unrealized -21.9%

AVBP ARRIVENT BIOPHARMA INC 2.3%

Value $35.83M Shares 1,942,142 Est. Cost $20.49 Unrealized -4.1%

BMRN BIOMARIN PHARMACEUTICAL INC 2.3%

Value $35.75M Shares 660,000 Est. Cost $77.70 Unrealized -26.4%

PCVX VAXCYTE INC 2.1%

Value $33M Shares 916,160 Est. Cost $39.88 Unrealized -16.9%

CLDX CELLDEX THERAPEUTICS INC NEW 2.0%

Value $31.04M Shares 1,200,000 Est. Cost $34.88 Unrealized -33.6%

ELVN ENLIVEN THERAPEUTICS INC 1.9%

Value $29.2M Shares 1,426,260 Est. Cost $19.23 Unrealized +4.9%

INSM INSMED INC 1.9%

Value $28.8M Shares 200,000 Est. Cost $23.10 Unrealized +430.3%

VALN VALNEVA SE 1.8%

Value $28.61M Shares 2,345,000 Est. Cost $5.67 Unrealized —

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 1.5%

Value $22.71M Shares 1,961,317 Est. Cost $11.58 Unrealized —

APGE APOGEE THERAPEUTICS INC 1.3%

Value $19.86M Shares 500,000 Est. Cost $38.06 Unrealized +0.3%

FDMT 4D MOLECULAR THERAPEUTICS IN 1.1%

Value $17.38M Shares 2,000,000 Est. Cost $14.31 Unrealized -58.2%

LNZA LANZATECH GLOBAL INC 0.2%

Value $3.876M Shares 158,148 Est. Cost $28.70 Unrealized 0.0%

MQ MARQETA INC 0.2%

Value $2.331M Shares 441,558 Est. Cost $22.37 Unrealized -73.5%

IOBT IO BIOTECH INC 0.1%

Value $912K Shares 2,512,453 Est. Cost $6.26 Unrealized -72.5%

GLTO GALECTO INC 0.0%

Value $322K Shares 86,579 Est. Cost $13.05 Unrealized -74.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	1,038,550	$341M	22.0%	$267.51	—	TOTAL STK MKT	922908769
BN	BROOKFIELD CORP	2,330,830	$160M	10.3%	$22.16	+99.4%	CL A LTD VT SH	11271J107
ASML	ASML HOLDING N V	145,836	$141M	9.1%	$662.32	—	N Y REGISTRY SHS	N07059210
MIRM	MIRUM PHARMACEUTICALS INC	1,264,028	$92.67M	6.0%	$12.27	+418.3%	COM	604749101
EWTX	EDGEWISE THERAPEUTICS INC	5,350,000	$86.78M	5.6%	$18.02	-21.3%	COM	28036F105
CRM	SALESFORCE INC	330,187	$78.25M	5.0%	$205.72	+22.2%	COM	79466L302
—	MERUS N V	750,000	$70.61M	4.6%	$56.95	—	COM	N5749R100
CRNX	CRINETICS PHARMACEUTICALS IN	1,625,000	$67.68M	4.4%	$25.38	+26.0%	COM	22663K107
VRDN	VIRIDIAN THERAPEUTICS INC	2,380,000	$51.36M	3.3%	$16.63	+8.5%	COM	92790C104
BABA	ALIBABA GROUP HLDG LTD	257,327	$45.99M	3.0%	$165.09	—	SPONSORED ADS	01609W102
ZBIO	ZENAS BIOPHARMA INC	2,000,000	$44.4M	2.9%	$14.60	+11.5%	COM	98937L105
PHVS	PHARVARIS N V	1,750,000	$43.66M	2.8%	$15.36	+44.4%	COM	N69605108
RXRX	RECURSION PHARMACEUTICALS IN	7,929,835	$38.7M	2.5%	$6.72	-21.9%	CL A	75629V104
AVBP	ARRIVENT BIOPHARMA INC	1,942,142	$35.83M	2.3%	$20.49	-4.1%	COM	04272N102
BMRN	BIOMARIN PHARMACEUTICAL INC	660,000	$35.75M	2.3%	$77.70	-26.4%	COM	09061G101
PCVX	VAXCYTE INC	916,160	$33M	2.1%	$39.88	-16.9%	COM	92243G108
CLDX	CELLDEX THERAPEUTICS INC NEW	1,200,000	$31.04M	2.0%	$34.88	-33.6%	COM NEW	15117B202
ELVN	ENLIVEN THERAPEUTICS INC	1,426,260	$29.2M	1.9%	$19.23	+4.9%	COM	29337E102
INSM	INSMED INC	200,000	$28.8M	1.9%	$23.10	+430.3%	COM PAR $.01	457669307
VALN	VALNEVA SE	2,345,000	$28.61M	1.8%	$5.67	—	SPONSORED ADS	92025Y103
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	1,961,317	$22.71M	1.5%	$11.58	—	COM NEW	107924102
APGE	APOGEE THERAPEUTICS INC	500,000	$19.86M	1.3%	$38.06	+0.3%	COM	03770N101
FDMT	4D MOLECULAR THERAPEUTICS IN	2,000,000	$17.38M	1.1%	$14.31	-58.2%	COM	35104E100
LNZA	LANZATECH GLOBAL INC	158,148	$3.876M	0.2%	$28.70	0.0%	COM NEW	51655R200
MQ	MARQETA INC	441,558	$2.331M	0.2%	$22.37	-73.5%	CLASS A COM	57142B104
IOBT	IO BIOTECH INC	2,512,453	$912K	0.1%	$6.26	-72.5%	COM	449778109
GLTO	GALECTO INC	86,579	$322K	0.0%	$13.05	-74.0%	COM NEW	36322Q206